December 2007

Zymenex has received a gracious grant from the ATHENA HOPE FOUNDATION of 15,000 USD to support the ongoing research and the clinical trial with Zymenex' recombinant enzyme Metazym, in patients suffering from the Lysosomal Disease, Metachromatic Leukodystrophy.

Zymenex A/S

Roskildevej 12 C
3400 Hillerød, DK

Tel +45 48250054
Fax +45 48251054

Affiliate Sweden

Dalénum 13
181 70 Lidingö, S

Tel +46 8 7670203
Fax +46 8 7670233